News
Nature Biotechnology 25, 369 - 370 (2007)
Published online: 3 April 2007 | doi:10.1038/nbt0407-369
UK parses merits of value-based drug pricing
Nuala Moran1
- London
Abstract
The UK's Office of Fair Trading is suggesting a system of drug pricing based on therapeutic value, which it believes would better focus innovation and investment toward creating more valuable drugs.


